FRPT
Freshpet, Inc.Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score Cluster buy
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-28 | Patel Nishu D. |
Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld upon vesting of restricted stock units to cover tax obligations. |
Common Stock
|
193 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Direct)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
|
62,369 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
(I)
|
7,981 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
Common Stock
(I)
|
923 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Indirect)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
(I)
|
7,981 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
Common Stock
(I)
|
1,803 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Indirect)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
(I)
|
9,030 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
Common Stock
(I)
|
1,593 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Indirect)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
(I)
|
4,620 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.98 to $50.97. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
Common Stock
|
13,215 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
(I)
|
9,030 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
(I)
|
4,620 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
|
62,369 |
| 2026-05-22 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.98 to $51.59. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
Common Stock
|
29,280 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Indirect)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
(I)
|
7,981 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
Common Stock
(I)
|
1,951 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Indirect)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
(I)
|
9,030 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Indirect)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
(I)
|
4,620 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
Common Stock
(I)
|
1,725 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
(I)
|
7,981 |
| 2026-05-20 | BREWSTER DARYL G |
Director |
Buy↑
|
Common Stock
|
211 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Direct)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
|
62,369 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
(I)
|
9,030 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
Common Stock
(I)
|
999 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
|
62,369 |
| 2026-05-20 | Steeneck Craig D. |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $47.45 to $48.18. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this Form 4. |
Common Stock
|
2,000 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
Common Stock
|
42,907 |
| 2026-05-20 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
(I)
|
4,620 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.90 to $49.46. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
Common Stock
|
1,526 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Direct)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
|
62,369 |
| 2026-05-18 | MCLEVISH TIMOTHY R |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $48.50 to $48.75. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this Form 4. |
Common Stock
|
3,000 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.89 to $48.88. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
Common Stock
|
32,344 |
| 2026-05-18 | Kelley Jacki Sue |
Director |
Buy↑
|
Common Stock
|
1,000 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Indirect)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
(I)
|
7,981 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
Common Stock
(I)
|
959 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
Common Stock
(I)
|
1,656 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Indirect)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
(I)
|
9,030 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
Common Stock
(I)
|
1,874 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
(I)
|
7,981 |
| 2026-05-18 | Biegger David |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $50.94 to $51.53. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this Form 4. |
Common Stock
|
138 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
(I)
|
4,620 |
| 2026-05-18 | Biegger David |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $49.72 to $50.49. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this Form 4. |
Common Stock
|
172 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
|
62,369 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.98 to $50.94. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
Common Stock
|
7,513 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
(I)
|
9,030 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Indirect)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
(I)
|
4,620 |
| 2026-05-18 | Cyr William B. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.03 to $51.68. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
Common Stock
|
1,309 |
| 2026-05-18 | Biegger David |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $47.98 to $48.93. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this Form 4. |
Common Stock
|
690 |
| 2026-05-15 | Cyr William B. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Options to purchase common stock (Indirect)
The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
Options to purchase common stock
(I)
|
9,030 |
| 2026-05-15 | Cyr William B. |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
(I)
|
7,981 |